Vasant Narasimhan is Chief Executive Officer for Novartis AG and Chief Executive Officer at Novartis International AG (a subsidiary of Novartis AG). Dr. Narasimhan is also on the board of Pharmaceutical Research & Manufacturers of America and Novartis Foundation and Member of National Academy of Medicine of United States and Member of Institute of Medicine.

Dr. Narasimhan previously held the position of President at Novartis Vaccines & Diagnostics, Inc., Global Head-Development at Novartis Pharmaceuticals, Global Head-Development at Sandoz Pharmaceuticals AG and Global Head-Development at Novartis Vaccines & Diagnostics, Inc.

Dr. Narasimhan received a graduate degree from Harvard Medical School, a graduate degree from Harvard Kennedy School of Government and an undergraduate degree from The University of Chicago.